RN

Rodger Novak

Serial Entrepreneur, long-time Pharmaceutical and Biotechnology Senior Executive, Board Director, Chair, Venture Partner

Switzerland

Investor
VC

Invests in

  • Min Investment:

    $500,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $2,800,000.00

Skills

Clinical Development
Infectious Diseases
Cell
Drug Discovery
Pharmaceutical Industry
In Vitro
Biotechnology
Biopharmaceuticals
Assay Development
Drug Development
Oncology
Clinical Trials
Lifesciences
Vaccines
Protein Chemistry
Clinical Research
CTMS
Technology Transfer
CRO
Cell Biology

Education

Lists including Rodger

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

A
AIRNA

2023

  • Chair of the Board of Directors

    2023

EB
Econic Biosciences

2022

  • Chair of the Board of Directors

    2022

XT
Xap Therapeutics

2020

  • Chair of the Board of Directors

    2020

SO
SR One Capital Management

2020

  • Venture Partner

    2020

EG
ERS Genomics

2014

  • Board Member

    2014

CT
CRISPR Therapeutics

2013 - 2023

  • President & Chair Board of Directors

    2017 - 2023

  • Chief Executive Officer

    2013 - 2017

S
Sanofi

2012 - 2013

  • VP Head TSU Infectious Diseases Global R&D

    2012 - 2013

NT
Nabriva Therapeutics AG

2006 - 2012

  • Founder and Chief Operating Officer

    2006 - 2012

S
Sandoz

2003 - 2005

  • Deputy Head Antibiotic Research Institute

    2003 - 2005

    Position accountable for the management of entire organization in preparation for spin-off from Sandoz/Novartis to foundation of Nabriva.

VB
Vienna BioCenter

2000 - 2003

  • University Professor

    2000 - 2003